Gene therapy for the hemoglobin disorders: Past, present, and future
Open Access
- 9 May 2000
- journal article
- review article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (10) , 5022-5024
- https://doi.org/10.1073/pnas.97.10.5022
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Analysis of gamma-Globin Expression Cassettes in Retrovirus VectorsHuman Gene Therapy, 1999
- The β-Globin LCR Is Not Necessary for an Open Chromatin Structure or Developmentally Regulated Transcription of the Native Mouse β-Globin LocusMolecular Cell, 1998
- Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cellsNature Medicine, 1998
- In vivo selection of retrovirally transduced hematopoietic stem cellsNature Medicine, 1998
- Knockout-Transgenic Mouse Model of Sickle Cell DiseaseScience, 1997
- Sustained High-Level Reconstitution of the Hematopoietic System by Preselected Hematopoietic Cells Expressing a Transduced Cell-Surface AntigenHuman Gene Therapy, 1997
- Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cellsNature Medicine, 1996
- Lineage-specific expression of a human β-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cellsNature, 1988
- Position-independent, high-level expression of the human β-globin gene in transgenic miceCell, 1987
- Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouseNature, 1984